Medtronic plc MDT has shared late-breaking clinical trial results for its PulseSelect Pulsed Field Ablation (“PFA”) system, demonstrating a high rate of durable lesion formation in treating atrial ...
"Medtronic’s PulseSelect system shows lesion durability in Afib treatment" was originally created and published by Medical ...
Medtronic presents positive data from PulseSelect PFA System in treating atrial fibrillation at APHRS meeting: Galway, Ireland Monday, September 30, 2024, 10:00 Hrs [IST] Medtroni ...
Medtronic plc (MDT) announced that clinical study results demonstrated a high rate of durable lesion formation using the PulseSelect ...
Far Eastern University pummeled San Sebastian College-Recoletos into submission, 25-14, 25-19, 25-20, for a rousing start in ...
Medtronic announced Japanese approval of the competing PulseSelect PFA system in May. “The Farapulse PFA system is the most ...